Genetics of Hypertension: Lessons Learnt from Mendelian and Polygenic Syndromes
Overview
Affiliations
This brief review discusses genetic and genomic aspects of hypertension. A special emphasis is given to currently available strategies for gene identifications, including studies of rare Mendelian hypertension, candidate gene evaluation, genome-wide scans and approaches based on the comparative genome analysis. We also discuss the growing potential for pharmacogenetic approaches and address briefly the issue of genetic testing in complex polygenic traits.
Biino G, Parati G, Concas M, Adamo M, Angius A, Vaccargiu S PLoS One. 2013; 8(3):e59612.
PMID: 23527229 PMC: 3603911. DOI: 10.1371/journal.pone.0059612.
Extensive natural variation for cellular hydrogen peroxide release is genetically controlled.
Attar H, Bedard K, Migliavacca E, Gagnebin M, Dupre Y, Descombes P PLoS One. 2012; 7(8):e43566.
PMID: 22952707 PMC: 3430705. DOI: 10.1371/journal.pone.0043566.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
Nature. 2007; 447(7145):661-78.
PMID: 17554300 PMC: 2719288. DOI: 10.1038/nature05911.
Hypertension in young children and neonates.
Jones J, Jose P Curr Hypertens Rep. 2006; 7(6):454-60.
PMID: 16386202 DOI: 10.1007/s11906-005-0041-0.